Drug
Spm927 Lacosamide
Spm927 Lacosamide: highest development phase Phase 2, developed by UCB. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- UCB
Trials
| Drug | Phase | Indication |
|---|---|---|
| SPM927/Lacosamide NCT00861042 | Phase 2 | Painful Diabetic Neuropathy |
Latest
No recent events.
Follow Spm927 Lacosamide on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.